Royal Marsden Nhs Foundation Trust

This study tested whether a drug called crizotinib, used for some lung cancers, could help control advanced lobular breast cancer and certain other hard-to-treat cancers. For breast cancer patients, it was combined with a hormone-blocking drug called fulvestrant. The main goal wa…

This early-stage trial tested a new oral drug, VS-6766, given alone and later combined with another drug called everolimus. The main goal was to find safe and tolerable dosing schedules for patients with advanced solid tumors or multiple myeloma that had stopped responding to sta…

This study aimed to find a safe dose for a new two-drug combination (pembrolizumab and gemcitabine) for patients with advanced leiomyosarcoma or undifferentiated pleomorphic sarcoma, two aggressive types of soft tissue cancer. It involved 25 patients and focused primarily on iden…

This study observed 153 cancer patients with suspected COVID-19 to understand how the infection affects them. Researchers tracked their immune responses over time using blood tests to measure COVID-19 antibodies. The goal was to gather information that helps doctors make better d…